James Sigafoos

Central Nervous System Disposition and Metabolism of Fosdevirine (GSK2248761), a Non-Nucleoside Reverse Transcriptase Inhibitor: An LC-MS and Matrix-Assisted Laser Desorption/Ionization Imaging MS Investigation into Central Nervous System Toxicity

Stephen Castellino, M. Reid Groseclose, James Sigafoos et al. · Chemical Research in Toxicology · 2012 · 76 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Assessment of the Drug Interaction Risk for Remogliflozin Etabonate, a Sodium-Dependent Glucose Cotransporter-2 Inhibitor: Evidence from In Vitro, Human Mass Balance, and Ketoconazole Interaction Studies

James Sigafoos, Gary D. Bowers, Stephen Castellino et al. · Drug Metabolism and Disposition · 2012 · 43 citations

Medicine, Pharmacokinetics, Pharmacology +17

Evaluation of a chimeric (uPA+/+)/SCID mouse model with a humanized liver for prediction of human metabolism

Mark de Serres, Gary D. Bowers, Gary Boyle et al. · Xenobiotica · 2011 · 34 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Disposition and Metabolism of GSK2251052 in Humans: A Novel Boron-Containing Antibiotic

Gary D. Bowers, David M. Tenero, Parul Patel et al. · Drug Metabolism and Disposition · 2013 · 24 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

Effects of<i>N</i>-Ethylmaleimide on Gonadotropin and<i>β</i>-Adrenergic Receptor Function Coupled to Rabbit Luteal Adenylyl Cyclase*

James Sigafoos, Joel Abramowitz · Endocrinology · 1986 · 10 citations

Life Sciences, Biochemistry, Pharmacology +15